Featured Articles
Analysis
What Oregon’s Measure 109 Means for Hopeful Entrepreneurs and Investors
While entrepreneurs and investors are likely to see Oregon’s Measure 109 as a chance to capitalize on new business opportunities and investments, it’s worth highlighting that this new law is unlikely to lead to a psilocybin gold rush.
Press
PharmaTher Announces Application with the FDA for Ketamine in the Treatment of Parkinson’s Disease
PharmaTher Holdings Ltd. today announced it submitted an Investigational New Drug application with the U.S. Food and Drug…
Press
Cybin Establishes Clinical Advisory Board of Renowned Physicians
Cybin Inc. today announced the formation of its Clinical Advisory Board.
Press
Ehave to Launch Ketamine Trials Using Brain Mapping Technology
Ehave, Inc. announced plans to launch brain mapping ketamine clinical trials using Brain Scientific technology later this year.
Press
Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brazil
Quick Take: Silo Wellness entered into an agreement with Jungle Med to distribute and sell their psilocybin nasal…
Analysis
New Research Confirms Multi Billion Dollar Investment Opportunity in Psychedelic Medicine
Even though it is a nascent industry, already hundreds of millions of dollars have been poured into the…
Track the entire psychedelic market using the only index that covers the entire psychedelics marketplace.
Explore the IndexAll Articles
- All
- Analysis
- Interviews
- Press